Furthermore, some CYP2E1 polymorphisms, particularly the c2 allele, has been shown to be associated with the development of NASH in obese, nondiabetic subjects, paving the way for a possible explanation about why not all the subjects with NAFLD go on to develop NASH [38]. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.